Primary and secondary thyroid hormone transporters

被引:71
作者
Kinne A. [1 ]
Schülein R. [1 ]
Krause G. [1 ]
机构
[1] Leibniz-Institut für Molekulare Pharmakologie (FMP), 13125 Berlin
关键词
Thyroid Hormone; Amino Acid Transporter; Major Facilitator Superfamily; Monocarboxylate Transporter; Large Neutral Amino Acid;
D O I
10.1186/1756-6614-4-S1-S7
中图分类号
学科分类号
摘要
Thyroid hormones (TH) are essential for the development of the human brain, growth and cellular metabolism. Investigation of TH transporters became one of the emerging fields in thyroid research after the discovery of inactivating mutations in the Monocarboxylate transporter 8 (MCT8), which was found to be highly specific for TH transport. However, additional transmembrane transporters are also very important for TH uptake and efflux in different cell types. They transport TH as secondary substrates and include the aromatic amino acid transporting MCT10, the organic anion transporting polypeptides (e.g. OATP1C1, OATP1A2, OPTP1A4) and the large neutral amino acid transporters (LAT1 and LAT2). These TH transporters characteristically possess 12 transmembrane spanners but due to the strong differing sequences between the three transporter families we assume an identical conformation is not very likely. In contrast to the others, the LAT family members form a heterodimer with the escort protein 4F2hc/CD98. A comparison of sequence proportions, locations and types of functional sensitive features for TH transport discovered by mutations, revealed that transport sensitive charged residues occur as conserved amino acids only within each family of the transporter types but not in all putative TH transporters. Based on the lack of highly conserved sensitive charged residues throughout the three transporter families as a common counterpart for the amino acid moiety of the substrates, we conclude that the molecular transport mechanism is likely organized either a) by different molecular determinants in the divergent transporter types or b) the counterparts for the substrates' amino acid moiety at the transporter are not any charged side chains but other proton acceptors or donators. However, positions of transport sensitive residues coincide at transmembrane helix 8 in the TH transporter MCT8, OATP1C1 and another amino acid transporter, the L-cystine and L-glutamate exchanger xCT, which is highly homologous to LAT1 and LAT2. Here we review the data available and compare similarities and differences between these primary and secondary TH transporters regarding sequences, topology, potential structures, trafficking to the plasma membrane, molecular features and locations of transport sensitive functionalities. Thereby, we focus on TH transporters occurring in the blood-brain barrier. © 2011 Kinne et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 86 条
[1]  
Friesema E.C.H., Grueters P.A., Biebermann H., Krude H., Von Moers A., Reeser M., Barrett T.G., Mancilla E.E., Svensson J., Kester M.H.A., Kuiper G.G.J.M., Balkassmi S., Uitterlinden A.G., Koehrle P.J., Rodien P., Halestrap P.A.P., Visser P.T.J., Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation, Lancet, 364, 9443, pp. 1435-1437, (2004)
[2]  
Brockmann K., Dumitrescu A.M., Best T.T., Hanefeld F., Refetoff S., X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene, Journal of Neurology, 252, 6, pp. 663-666, (2005)
[3]  
Dumitrescu A.M., Liao X.-H., Best T.B., Brockmann K., Refetoff S., A Novel Syndrome Combining Thyroid and Neurological Abnormalities Is Associated with Mutations in a Monocarboxylate Transporter Gene, American Journal of Human Genetics, 74, 1, pp. 168-175, (2004)
[4]  
Schwartz C.E., May M.M., Carpenter N.J., Rogers R.C., Martin J., Bialer M.G., Ward J., Sanabria J., Marsa S., Lewis J.A., Echeverri R., Lubs H.A., Voeller K., Simensen R.J., Stevenson R.E., Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene, American Journal of Human Genetics, 77, 1, pp. 41-53, (2005)
[5]  
Herzovich V., Vaiani E., Marino R., Dratler G., Lazzati J.M., Tilitzky S., Ramirez P., Iorcansky S., Rivarola M.A., Belgorosky A., Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene, Horm Res, 67, pp. 1-6, (2007)
[6]  
Maranduba C.M., Friesema E.C., Kok F., Kester M.H., Jansen J., Sertie A.L., Passos-Bueno M.R., Visser T.J., Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter, J Med Genet, 43, pp. 457-460, (2006)
[7]  
Zoeller R.T., Rovet J., Timing of thyroid hormone action in the developing brain: Clinical observations and experimental findings, Journal of Neuroendocrinology, 16, 10, pp. 809-818, (2004)
[8]  
Zoeller R.T., Dowling A.L.S., Herzig C.T.A., Iannacone E.A., Gauger K.J., Bansal R., Thyroid hormone, brain development, and the environment, Environmental Health Perspectives, 110, SUPPL. 3, pp. 355-361, (2002)
[9]  
Bernal J., Iodine and brain development, BioFactors, 10, 2-3, pp. 271-276, (1999)
[10]  
Wirth E.K., Roth S., Blechschmidt C., Holter S.M., Becker L., Racz I., Zimmer A., Klopstock T., Gailus-Durner V., Fuchs H., Et al., Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome, J Neurosci, 29, pp. 9439-9449, (2009)